| Amar D Patel, MD | |
|
55 Whitcher St Ne, Suite 350, Marietta, GA 30060-1155 | |
| (770) 424-6893 | |
| (770) 528-9938 |
| Full Name | Amar D Patel |
|---|---|
| Gender | Male |
| Speciality | Interventional Cardiology |
| Experience | 24 Years |
| Location | 55 Whitcher St Ne, Marietta, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750402491 | NPI | - | NPPES |
| 676510104F | Medicaid | GA | |
| 676510104H | Medicaid | GA | |
| 676510104G | Medicaid | GA | |
| 676510104I | Medicaid | GA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 52803 (Georgia) | Secondary |
| 207RI0011X | Internal Medicine - Interventional Cardiology | 52803 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Wellstar Kennestone Hospital | Marietta, GA | Hospital |
| Wellstar Paulding Hospital | Hiram, GA | Hospital |
| Wellstar West Georgia Medical Center | Lagrange, GA | Hospital |
| Wellstar Cobb Hospital | Austell, GA | Hospital |
| Wellstar Douglas Hospital | Douglasville, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wellstar Medical Group, Llc | 6709065402 | 1839 |
News Archive
AbbVie announced today the initiation of a Phase 3 clinical study called SONAR (Study Of Diabetic Nephropathy with Atrasentan) to assess the effects of the investigational compound atrasentan - when added to standard of care - on progression of kidney disease in patients with stage 2 to 4 chronic kidney disease and type 2 diabetes.
The National Cancer Institute has awarded a five-year, $10.7 million grant to Virginia Commonwealth University Massey Cancer Center researchers to develop a new form of radiation therapy that will enable the safe administration of more aggressive cancer treatments.
The former Arkansas governor's comments, offered as part of a speech to the Republican National Committee's winter meeting, drew harsh responses from Planned Parenthood and Democratic Party committees.
CombiMatrix Corporation announced today that it is implementing a restructuring plan to significantly reduce operating costs, increase the focus on the Company's diagnostic services business and transition senior management. After the restructuring, CombiMatrix will be focused on its diagnostics services business, including increasing utilization of its existing tests, expanding the test menu, increasing the number of customers and partners, and improving reimbursement for its testing services.
› Verified 4 days ago
| Entity Name | Hamilton Medical Center, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528056066 PECOS PAC ID: 0446151179 Enrollment ID: O20040116000053 |
News Archive
AbbVie announced today the initiation of a Phase 3 clinical study called SONAR (Study Of Diabetic Nephropathy with Atrasentan) to assess the effects of the investigational compound atrasentan - when added to standard of care - on progression of kidney disease in patients with stage 2 to 4 chronic kidney disease and type 2 diabetes.
The National Cancer Institute has awarded a five-year, $10.7 million grant to Virginia Commonwealth University Massey Cancer Center researchers to develop a new form of radiation therapy that will enable the safe administration of more aggressive cancer treatments.
The former Arkansas governor's comments, offered as part of a speech to the Republican National Committee's winter meeting, drew harsh responses from Planned Parenthood and Democratic Party committees.
CombiMatrix Corporation announced today that it is implementing a restructuring plan to significantly reduce operating costs, increase the focus on the Company's diagnostic services business and transition senior management. After the restructuring, CombiMatrix will be focused on its diagnostics services business, including increasing utilization of its existing tests, expanding the test menu, increasing the number of customers and partners, and improving reimbursement for its testing services.
› Verified 4 days ago
| Entity Name | Hamilton Physician Group, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235455569 PECOS PAC ID: 4789708553 Enrollment ID: O20100831000467 |
News Archive
AbbVie announced today the initiation of a Phase 3 clinical study called SONAR (Study Of Diabetic Nephropathy with Atrasentan) to assess the effects of the investigational compound atrasentan - when added to standard of care - on progression of kidney disease in patients with stage 2 to 4 chronic kidney disease and type 2 diabetes.
The National Cancer Institute has awarded a five-year, $10.7 million grant to Virginia Commonwealth University Massey Cancer Center researchers to develop a new form of radiation therapy that will enable the safe administration of more aggressive cancer treatments.
The former Arkansas governor's comments, offered as part of a speech to the Republican National Committee's winter meeting, drew harsh responses from Planned Parenthood and Democratic Party committees.
CombiMatrix Corporation announced today that it is implementing a restructuring plan to significantly reduce operating costs, increase the focus on the Company's diagnostic services business and transition senior management. After the restructuring, CombiMatrix will be focused on its diagnostics services business, including increasing utilization of its existing tests, expanding the test menu, increasing the number of customers and partners, and improving reimbursement for its testing services.
› Verified 4 days ago
| Entity Name | Wellstar Medical Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558664003 PECOS PAC ID: 6709065402 Enrollment ID: O20110127000374 |
News Archive
AbbVie announced today the initiation of a Phase 3 clinical study called SONAR (Study Of Diabetic Nephropathy with Atrasentan) to assess the effects of the investigational compound atrasentan - when added to standard of care - on progression of kidney disease in patients with stage 2 to 4 chronic kidney disease and type 2 diabetes.
The National Cancer Institute has awarded a five-year, $10.7 million grant to Virginia Commonwealth University Massey Cancer Center researchers to develop a new form of radiation therapy that will enable the safe administration of more aggressive cancer treatments.
The former Arkansas governor's comments, offered as part of a speech to the Republican National Committee's winter meeting, drew harsh responses from Planned Parenthood and Democratic Party committees.
CombiMatrix Corporation announced today that it is implementing a restructuring plan to significantly reduce operating costs, increase the focus on the Company's diagnostic services business and transition senior management. After the restructuring, CombiMatrix will be focused on its diagnostics services business, including increasing utilization of its existing tests, expanding the test menu, increasing the number of customers and partners, and improving reimbursement for its testing services.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Amar D Patel, MD 55 Whitcher St Ne, Suite 350, Marietta, GA 30060-1155 Ph: (770) 424-6893 | Amar D Patel, MD 55 Whitcher St Ne, Suite 350, Marietta, GA 30060-1155 Ph: (770) 424-6893 |
News Archive
AbbVie announced today the initiation of a Phase 3 clinical study called SONAR (Study Of Diabetic Nephropathy with Atrasentan) to assess the effects of the investigational compound atrasentan - when added to standard of care - on progression of kidney disease in patients with stage 2 to 4 chronic kidney disease and type 2 diabetes.
The National Cancer Institute has awarded a five-year, $10.7 million grant to Virginia Commonwealth University Massey Cancer Center researchers to develop a new form of radiation therapy that will enable the safe administration of more aggressive cancer treatments.
The former Arkansas governor's comments, offered as part of a speech to the Republican National Committee's winter meeting, drew harsh responses from Planned Parenthood and Democratic Party committees.
CombiMatrix Corporation announced today that it is implementing a restructuring plan to significantly reduce operating costs, increase the focus on the Company's diagnostic services business and transition senior management. After the restructuring, CombiMatrix will be focused on its diagnostics services business, including increasing utilization of its existing tests, expanding the test menu, increasing the number of customers and partners, and improving reimbursement for its testing services.
› Verified 4 days ago
Anu Kurl, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 400 Tower Rd Ne Ste 160, Marietta, GA 30060 Phone: 770-420-1690 Fax: 770-420-1661 | |
Dr. Sharon M Odell, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 54 Tower Rd Ne, Marietta, GA 30060 Phone: 770-427-4682 Fax: 770-499-8562 | |
Dr. Helga Annalina Bahr, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 580 Atlanta Country Club Drive, Marietta, GA 30068 Phone: 770-988-8554 | |
Dr. Kaynessa Celena Providence, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 54 Tower Rd Ne, Marietta, GA 30060 Phone: 770-427-4682 Fax: 770-499-8562 | |
Dr. Ryan V Cantwell, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 320 Kennestone Hospital Blvd, Suite 201, Marietta, GA 30060 Phone: 770-427-2457 Fax: 770-427-2706 | |
Dr. Joanne Zhiwen Zhu, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 677 Church St Ne # 111, Marietta, GA 30060 Phone: 770-793-7750 | |
Asif A Saberi, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 55 Whitcher St Ne, Suite 160, Marietta, GA 30060 Phone: 770-422-1372 Fax: 770-423-9651 |